(H049) Suitability of a routine next generation sequencing assay (NGS) for residual disease detection in acute myeloid leukemia (AML) patients

Saturday, November 18, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Ayei Chang (she/her/hers)

Undergraduate Researcher
Saint Louis Universtiy
Orlando, Florida, United States